Illinois Municipal Retirement Fund Boosts Stock Position in Avanos Medical, Inc. (NYSE:AVNS)

Illinois Municipal Retirement Fund lifted its stake in Avanos Medical, Inc. (NYSE:AVNS) by 4.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 29,084 shares of the company’s stock after buying an additional 1,262 shares during the quarter. Illinois Municipal Retirement Fund owned approximately 0.06% of Avanos Medical worth $652,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of AVNS. SG Americas Securities LLC boosted its stake in shares of Avanos Medical by 391.1% in the third quarter. SG Americas Securities LLC now owns 26,306 shares of the company’s stock worth $532,000 after buying an additional 20,949 shares during the last quarter. Bailard Inc. boosted its stake in shares of Avanos Medical by 16.4% in the third quarter. Bailard Inc. now owns 16,013 shares of the company’s stock worth $324,000 after buying an additional 2,251 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Avanos Medical by 52.9% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,627 shares of the company’s stock worth $195,000 after buying an additional 3,330 shares during the last quarter. Paradice Investment Management LLC boosted its stake in shares of Avanos Medical by 1.3% in the third quarter. Paradice Investment Management LLC now owns 2,272,758 shares of the company’s stock worth $45,955,000 after buying an additional 28,323 shares during the last quarter. Finally, Barclays PLC raised its holdings in Avanos Medical by 24.4% in the 3rd quarter. Barclays PLC now owns 39,042 shares of the company’s stock worth $790,000 after purchasing an additional 7,646 shares during the period. Hedge funds and other institutional investors own 95.17% of the company’s stock.

Insider Buying and Selling at Avanos Medical

In other Avanos Medical news, CFO Michael Greiner sold 8,000 shares of the stock in a transaction that occurred on Thursday, March 14th. The stock was sold at an average price of $19.12, for a total transaction of $152,960.00. Following the completion of the transaction, the chief financial officer now owns 151,495 shares of the company’s stock, valued at $2,896,584.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 2.90% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com raised Avanos Medical from a “hold” rating to a “buy” rating in a report on Tuesday, March 19th.

Avanos Medical Stock Performance

NYSE AVNS opened at $18.62 on Tuesday. The stock has a market capitalization of $860.07 million, a price-to-earnings ratio of -14.10 and a beta of 0.96. Avanos Medical, Inc. has a twelve month low of $17.24 and a twelve month high of $30.26. The company has a current ratio of 2.08, a quick ratio of 1.38 and a debt-to-equity ratio of 0.13. The stock has a 50-day moving average of $19.23 and a 200 day moving average of $19.90.

Avanos Medical (NYSE:AVNS) last released its quarterly earnings results on Tuesday, February 20th. The company reported $0.36 earnings per share for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.01). The business had revenue of $173.30 million during the quarter, compared to analyst estimates of $170.43 million. Avanos Medical had a positive return on equity of 4.25% and a negative net margin of 8.76%. The business’s revenue for the quarter was down 4.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.60 EPS. Sell-side analysts anticipate that Avanos Medical, Inc. will post 1.38 EPS for the current fiscal year.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.